Company Profile
Addus Homecare Stock Price, News & Analysis
- Ticker:
- ADUS
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- United States
Stock performance
108.86 USD (+0.60%)
Close
Last updated: July 13, 2026 at 00:00
2.02B USD
Market cap
Why the stock is moving
ADUS is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Addus Homecare is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Addus Homecare is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Addus Homecare follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Addus Homecare sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Zimmer Biomet Names Chintan Desai President of Asia Pacific Region
ZBH · Source: Zimmer Biomet
- 02
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results
ZBH · Source: Zimmer Biomet
- 03
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma
BMY · Source: BMYBristol-Myers Squibb Company
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Addus Homecare (ADUS)?
Addus Homecare (ADUS) most recently closed at 108.86 USD, a +0.60% move versus the previous session.
What is the market cap of Addus Homecare (ADUS)?
Addus Homecare currently has a market capitalization of 2.02B USD on BioPharmSignal.
What does Addus Homecare do?
Addus Homecare is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is ADUS stock listed?
Addus Homecare (ADUS) is associated with NASDAQ, United States, Biotechnology.
What is Addus?
Addus Homecare is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Addus Homecare targeting with Addus?
Addus Homecare is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Homecare?
Addus Homecare is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.